Evaluation of blood inflammatory parameters of infants with premature retinopathy treated with intravitreal anti vascular endothelial growth factor

dc.authorid0000-0001-8856-0528en_US
dc.authorid0000-0002-8206-781Xen_US
dc.authorid0000-0002-3591-721Xen_US
dc.authorid0000-0001-5742-1293en_US
dc.authorid0000-0003-3346-3290en_US
dc.authorid0000-0003-2348-4856en_US
dc.contributor.authorAva, Sedat
dc.contributor.authorHazar, Leyla
dc.contributor.authorKarahan, Mine
dc.contributor.authorErdem, Seyfettin
dc.contributor.authorDursun, Mehmet Emin
dc.contributor.authorKeklikçi, Uğur
dc.date.accessioned2023-05-26T10:29:40Z
dc.date.available2023-05-26T10:29:40Z
dc.date.issued2022en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalıen_US
dc.description.abstractPurpose: This study compared the blood inflammatory parameters between early preterm infants with retinopathy of prematurity (ROP) who were treated with intravitreal anti-vascular endothelial growth factor (VEGF)) and those who did not need treatment. Materials and Methods: One hundred and six infants were included in the study. Early preterm infants with a gestational age (GA) ≤ 32 weeks and birth weight (BW) ≤ 1500 gm were included. These infants were divided into three groups: infants without ROP (group 1), infants with ROP who did not require treatment (group 2) and infants with ROP who were treated with intravitreal anti-VEGF (group 3). In the first week, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) and platelet-to-lymphocyte ratio (PLR) of the groups were calculated and compared. Results: Of 106 infants, 38 (35.8%) were in group 1, 30 (28.3%) were in group 2 and 38 (35.8%) were in group 3. GA was 24.89 ± 1.48 weeks, and BW was significantly lower in group 3, 775.21 ± 175.11 gm. (p < 0.001). There was no significant difference between the groups in terms of NLR, MLR and PLR (p = 0.833, p = 0.918 and p = 0.082, respectively). Logistic regression analysis was performed; BW was a statistically significant independent risk factor (OR: 0,999 %CI: 0,992-0,999 p = 0.022) associated with ROP that required treatment. Conclusion: It was shown that systemic inflammation parameters, including NLR, MLR and PLR, are not a reliable marker in the diagnosis and prognosis of ROP.en_US
dc.identifier.citationAva, S., Hazar, L., Karahan, M., Erdem, S., Dursun, M. ve Keklikçi, U. (2022). Evaluation of blood inflammatory parameters of infants with premature retinopathy treated with intravitreal anti vascular endothelial growth factor. Retina-Vitreus, 31(2), 134-139.en_US
dc.identifier.doi10.37845/ret.vit.2022.31.23
dc.identifier.endpage139en_US
dc.identifier.issn1300-1256
dc.identifier.issn2717-7149
dc.identifier.issue2en_US
dc.identifier.startpage134en_US
dc.identifier.trdizinid1122610
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1122610
dc.identifier.urihttps://hdl.handle.net/11468/11929
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1122610
dc.identifier.volume31en_US
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorAva, Sedat
dc.institutionauthorHazar, Leyla
dc.institutionauthorKarahan, Mine
dc.institutionauthorErdem, Seyfettin
dc.institutionauthorDursun, Mehmet Emin
dc.institutionauthorKeklikçi, Uğur
dc.language.isoenen_US
dc.publisherGazi Göz Vakfıen_US
dc.relation.ispartofRetina-Vitreus
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRetinopathy of prematurityen_US
dc.subjectNeutrophil-to-lymphocyte ratioen_US
dc.subjectMonocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratioen_US
dc.titleEvaluation of blood inflammatory parameters of infants with premature retinopathy treated with intravitreal anti vascular endothelial growth factoren_US
dc.titleEvaluation of blood inflammatory parameters of infants with premature retinopathy treated with intravitreal anti vascular endothelial growth factor
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Evaluation of Blood Inflammatory Parameters of Infants.pdf
Boyut:
348.23 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: